DOCSLIB.ORG

National Survey on Drug Use and Health

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Survey on Drug Use and Health Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS), under Contract No. HHSS283201700002C with RTI International. Beth Han was the SAMHSA author. Kathryn Piscopo served as the government project officer and as the contracting officer representative. Public Domain Notice All material appearing in this report is in the public domain and may be reproduced or copied without permission from SAMHSA. Citation of the source is appreciated. However, this publication may not be reproduced or distributed for a fee without the specific, written authorization of the Office of Communications, SAMHSA, HHS. Electronic Access and Printed Copies This publication may be downloaded or ordered at https://store.samhsa.gov/. Or call SAMHSA at 1-877-SAMHSA-7 (1-877-726-4727) (English and Español). Recommended Citation Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/ Originating Office Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Room 15-E09D, Rockville, MD 20857. For questions about this report, please e-mail [email protected]. Nondiscrimination Notice SAMHSA complies with applicable federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. SAMHSA cumple con las leyes federales de derechos civiles aplicables y no discrimina por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality Populations Survey Branch Publication Number PEP20-07-01-001 September 2020 Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health September 2020 | iii Table of Contents Summary ������������������������������������������������������������������������������������1 Perceived Risk from Substance Use �����������������������������������������32 Perceived Risk from Substance Use among Adolescents ................33 Introduction ��������������������������������������������������������������������������������7 Perceived Risk from Substance Use among Young Adults ...............33 Survey Background ��������������������������������������������������������������������7 Perceived Risk from Substance Use among Adults Aged 26 or Older ............................................................................33 Data Presentation and Interpretation ������������������������������������������8 Age Comparisons for Perceived Risk from Substance Use ..............34 Substance Use in the Past Month �����������������������������������������������8 Substance Use Disorders in the Past Year ��������������������������������34 Tobacco Use in the Past Month ���������������������������������������������������9 Alcohol Use Disorder ...................................................................35 Cigarette Use ..............................................................................10 Illicit Drug Use Disorder................................................................35 Daily Cigarette Use ......................................................................10 Marijuana Use Disorder ................................................................36 Cocaine Use Disorder ..................................................................37 Alcohol Use in the Past Month ��������������������������������������������������12 Heroin Use Disorder .....................................................................37 Any Alcohol Use ..........................................................................12 Methamphetamine Use Disorder ...................................................38 Binge Alcohol Use ........................................................................13 Prescription Stimulant Use Disorder ..............................................38 Heavy Alcohol Use .......................................................................13 Prescription Tranquilizer or Sedative Use Disorder ..........................39 Underage Alcohol Use .................................................................14 Prescription Pain Reliever Use Disorder .........................................39 Kratom Use in the Past Month ��������������������������������������������������14 Opioid Use Disorder .....................................................................40 Substance Use Disorder (Alcohol or Illicit Drugs) ............................40 Illicit Drug Use in the Past Year �������������������������������������������������14 Any Illicit Drug Use ......................................................................14 Major Depressive Episode in the Past Year �������������������������������41 Marijuana Use .............................................................................15 MDE and MDE with Severe Impairment among Adolescents ..........42 Cocaine Use ...............................................................................16 MDE and MDE with Severe Impairment among Adults ....................42 Heroin Use ..................................................................................17 Any Mental Illness among Adults in the Past Year ��������������������43 Methamphetamine Use ................................................................18 Hallucinogen Use ........................................................................18 Serious Mental Illness among Adults in the Past Year ��������������44 Inhalant Use ................................................................................19 Co‑Occurring MDE and SUD among Adolescents ����������������������45 Misuse of Psychotherapeutic Drugs ..............................................20 Stimulant Misuse ........................................................................20 Substance Use among Adolescents with MDE ��������������������������45 Tranquilizer or Sedative Misuse ....................................................21 Co‑Occurring Mental Health Issues and SUD among Adults �����46 Benzodiazepine Misuse ................................................................21 Co-Occurring AMI and SUD ..........................................................46 Pain Reliever Misuse ..................................................................22 Co-Occurring SMI and SUD ..........................................................47 Opioid Misuse .............................................................................24 Substance Use among Adults, by Mental Illness Status �����������47 Initiation of Substance Use �������������������������������������������������������25 Initiation of Cigarette Smoking .....................................................26 Suicidal Thoughts and Behavior among Adults �������������������������48 Initiation of Alcohol Use ................................................................26 Had Serious Thoughts of Suicide ..................................................48 Initiation of Marijuana Use ............................................................27 Made a Suicide Plan ....................................................................49 Initiation of Cocaine Use ...............................................................28 Attempted Suicide .......................................................................50 Initiation of Heroin Use .................................................................28 Substance Use Treatment in the Past Year �������������������������������50 Initiation of Methamphetamine Use ...............................................29 Need for Substance Use Treatment ...............................................50 Initiation of Hallucinogen Use........................................................29 Receipt of Substance Use Treatment ............................................51 Initiation of Inhalant Use ...............................................................29 Perceived Need for Substance Use Treatment ................................53 Initiation of Prescription Stimulant Misuse .....................................30 Reasons for Not Receiving Substance Use Treatment ....................54 Initiation of Prescription Tranquilizer or Sedative Misuse .................30 Medication-Assisted Treatment for Alcohol Use or Opioid Misuse ....55 Initiation of Prescription Pain Reliever Misuse ................................31 Key Substance Use and Mental Health Indicators in the United States: iv | September 2020 Results from the 2019 National Survey on Drug Use and Health Mental Health Service Use in the Past Year ������������������������������55 Treatment for Depression among Adolescents ...............................55 Treatment for Depression among Adults ........................................56
Load more

Recommended publications
  • First Episode Psychosis an Information Guide Revised Edition
    First episode psychosis An information guide revised edition Sarah Bromley, OT Reg (Ont) Monica Choi, MD, FRCPC Sabiha Faruqui, MSc (OT) i First episode psychosis An information guide Sarah Bromley, OT Reg (Ont) Monica Choi, MD, FRCPC Sabiha Faruqui, MSc (OT) A Pan American Health Organization / World Health Organization Collaborating Centre ii Library and Archives Canada Cataloguing in Publication Bromley, Sarah, 1969-, author First episode psychosis : an information guide : a guide for people with psychosis and their families / Sarah Bromley, OT Reg (Ont), Monica Choi, MD, Sabiha Faruqui, MSc (OT). -- Revised edition. Revised edition of: First episode psychosis / Donna Czuchta, Kathryn Ryan. 1999. Includes bibliographical references. Issued in print and electronic formats. ISBN 978-1-77052-595-5 (PRINT).--ISBN 978-1-77052-596-2 (PDF).-- ISBN 978-1-77052-597-9 (HTML).--ISBN 978-1-77052-598-6 (ePUB).-- ISBN 978-1-77114-224-3 (Kindle) 1. Psychoses--Popular works. I. Choi, Monica Arrina, 1978-, author II. Faruqui, Sabiha, 1983-, author III. Centre for Addiction and Mental Health, issuing body IV. Title. RC512.B76 2015 616.89 C2015-901241-4 C2015-901242-2 Printed in Canada Copyright © 1999, 2007, 2015 Centre for Addiction and Mental Health No part of this work may be reproduced or transmitted in any form or by any means electronic or mechanical, including photocopying and recording, or by any information storage and retrieval system without written permission from the publisher—except for a brief quotation (not to exceed 200 words) in a review or professional work. This publication may be available in other formats. For information about alterna- tive formats or other CAMH publications, or to place an order, please contact Sales and Distribution: Toll-free: 1 800 661-1111 Toronto: 416 595-6059 E-mail: [email protected] Online store: http://store.camh.ca Website: www.camh.ca Disponible en français sous le titre : Le premier épisode psychotique : Guide pour les personnes atteintes de psychose et leur famille This guide was produced by CAMH Publications.
    [Show full text]
  • An Introduction to Psychometric Theory with Applications in R
    What is psychometrics? What is R? Where did it come from, why use it? Basic statistics and graphics TOD An introduction to Psychometric Theory with applications in R William Revelle Department of Psychology Northwestern University Evanston, Illinois USA February, 2013 1 / 71 What is psychometrics? What is R? Where did it come from, why use it? Basic statistics and graphics TOD Overview 1 Overview Psychometrics and R What is Psychometrics What is R 2 Part I: an introduction to R What is R A brief example Basic steps and graphics 3 Day 1: Theory of Data, Issues in Scaling 4 Day 2: More than you ever wanted to know about correlation 5 Day 3: Dimension reduction through factor analysis, principal components analyze and cluster analysis 6 Day 4: Classical Test Theory and Item Response Theory 7 Day 5: Structural Equation Modeling and applied scale construction 2 / 71 What is psychometrics? What is R? Where did it come from, why use it? Basic statistics and graphics TOD Outline of Day 1/part 1 1 What is psychometrics? Conceptual overview Theory: the organization of Observed and Latent variables A latent variable approach to measurement Data and scaling Structural Equation Models 2 What is R? Where did it come from, why use it? Installing R on your computer and adding packages Installing and using packages Implementations of R Basic R capabilities: Calculation, Statistical tables, Graphics Data sets 3 Basic statistics and graphics 4 steps: read, explore, test, graph Basic descriptive and inferential statistics 4 TOD 3 / 71 What is psychometrics? What is R? Where did it come from, why use it? Basic statistics and graphics TOD What is psychometrics? In physical science a first essential step in the direction of learning any subject is to find principles of numerical reckoning and methods for practicably measuring some quality connected with it.
    [Show full text]
  • Resource Document on Social Determinants of Health
    APA Resource Document Resource Document on Social Determinants of Health Approved by the Joint Reference Committee, June 2020 "The findings, opinions, and conclusions of this report do not necessarily represent the views of the officers, trustees, or all members of the American Psychiatric Association. Views expressed are those of the authors." —APA Operations Manual. Prepared by Ole Thienhaus, MD, MBA (Chair), Laura Halpin, MD, PhD, Kunmi Sobowale, MD, Robert Trestman, PhD, MD Preamble: The relevance of social and structural factors (see Appendix 1) to health, quality of life, and life expectancy has been amply documented and extends to mental health. Pertinent variables include the following (Compton & Shim, 2015): • Discrimination, racism, and social exclusion • Adverse early life experiences • Poor education • Unemployment, underemployment, and job insecurity • Income inequality • Poverty • Neighborhood deprivation • Food insecurity • Poor housing quality and housing instability • Poor access to mental health care All of these variables impede access to care, which is critical to individual health, and the attainment of social equity. These are essential to the pursuit of happiness, described in this country’s founding document as an “inalienable right.” It is from this that our profession derives its duty to address the social determinants of health. A. Overview: Why Social Determinants of Health (SDOH) Matter in Mental Health Social determinants of health describe “the causes of the causes” of poor health: the conditions in which individuals are “born, grow, live, work, and age” that contribute to the development of both physical and psychiatric pathology over the course of one’s life (Sederer, 2016). The World Health Organization defines mental health as “a state of well-being in which every individual realizes his or her own potential, can cope with the normal stresses of life, can work productively and fruitfully, and is able to make a contribution to her or his community” (World Health Organization, 2014).
    [Show full text]
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Information for Behavioral Health Providers in Primary Care Hallucinogens - LSD, Peyote, Psilocybin, and PCP What are Hallucinogens? Hallucinogenic compounds found in some plants and mushrooms (or their extracts) have been used— mostly during religious rituals—for centuries. Almost all hallucinogens contain nitrogen and are classified as alkaloids. Many hallucinogens have chemical structures similar to those of natural neurotransmitters (e.g., acetylcholine-, serotonin-, or catecholamine-like). While the exact mechanisms by which hallucinogens exert their effects remain unclear, research suggests that these drugs work, at least partially, by temporarily interfering with neurotransmitter action or by binding to their receptor sites. This InfoFacts will discuss four common types of hallucinogens: LSD (d-lysergic acid diethylamide) is one of the most potent mood-changing chemicals. It was discovered in 1938 and is manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains. Peyote is a small, spineless cactus in which the principal active ingredient is mescaline. This plant has been used by natives in northern Mexico and the southwestern United States as a part of religious ceremonies. Mescaline can also be produced through chemical synthesis. Psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) is obtained from certain types of mushrooms that are indigenous to tropical and subtropical regions of South America, Mexico, and the United States. These mushrooms typically contain less than 0.5 percent psilocybin plus trace amounts of psilocin, another hallucinogenic substance. PCP (phencyclidine) was developed in the 1950s as an intravenous anesthetic. Its use has since been discontinued due to serious adverse effects. How Are Hallucinogens Abused? The very same characteristics that led to the incorporation of hallucinogens into ritualistic or spiritual traditions have also led to their propagation as drugs of abuse.
    [Show full text]
  • Drug and Alcohol Abuse Prevention Handbook FOREWARD
    Drug and Alcohol Abuse Prevention Handbook FOREWARD Grayson College recognizes that the illicit use of drugs and/or the abuse of alcohol are a persistent health problem of major proportion affecting our society physically, mentally, and socially. Illicit drug use and /or alcohol abuse can adversely affect an individual’s personal life, safety, health, and mental and physical performance. It is the intent of GC to provide employees and students pertinent information related to illicit drug use and/or alcohol abuse in an effort to prevent such harm. GC is committed to promoting and maintaining a work and academic environment that is free from illegal alcohol and drug use and abuse, in accordance with all federal, state, and local laws. Students, employees, and visitors are prohibited from possessing, consuming, manufacturing, dispensing, or being under the influence of alcohol/illegal drugs or engaging in improper self- medication while on college property or college business. Any member of the college community who violates this policy is subject to both prosecution and punishment under federal, state, and local laws to disciplinary proceedings by the college. This alcohol/drug policy is not designed to punish people for seeking rehabilitation. All information about those individuals who voluntarily avail themselves of drug or alcohol counseling or rehabilitation will not be used as a basis for disciplinary action or be used against an individual in any way. College employees and students who violate the alcohol/drug policy shall be informed about and referred to services to assist them in determining whether they are abusing drugs and alcohol or are chemically dependent.
    [Show full text]
  • Cluster Analysis for Gene Expression Data: a Survey
    Cluster Analysis for Gene Expression Data: A Survey Daxin Jiang Chun Tang Aidong Zhang Department of Computer Science and Engineering State University of New York at Buffalo Email: djiang3, chuntang, azhang @cse.buffalo.edu Abstract DNA microarray technology has now made it possible to simultaneously monitor the expres- sion levels of thousands of genes during important biological processes and across collections of related samples. Elucidating the patterns hidden in gene expression data offers a tremen- dous opportunity for an enhanced understanding of functional genomics. However, the large number of genes and the complexity of biological networks greatly increase the challenges of comprehending and interpreting the resulting mass of data, which often consists of millions of measurements. A first step toward addressing this challenge is the use of clustering techniques, which is essential in the data mining process to reveal natural structures and identify interesting patterns in the underlying data. Cluster analysis seeks to partition a given data set into groups based on specified features so that the data points within a group are more similar to each other than the points in different groups. A very rich literature on cluster analysis has developed over the past three decades. Many conventional clustering algorithms have been adapted or directly applied to gene expres- sion data, and also new algorithms have recently been proposed specifically aiming at gene ex- pression data. These clustering algorithms have been proven useful for identifying biologically relevant groups of genes and samples. In this paper, we first briefly introduce the concepts of microarray technology and discuss the basic elements of clustering on gene expression data.
    [Show full text]
  • Reliability Engineering: Today and Beyond
    Reliability Engineering: Today and Beyond Keynote Talk at the 6th Annual Conference of the Institute for Quality and Reliability Tsinghua University People's Republic of China by Professor Mohammad Modarres Director, Center for Risk and Reliability Department of Mechanical Engineering Outline – A New Era in Reliability Engineering – Reliability Engineering Timeline and Research Frontiers – Prognostics and Health Management – Physics of Failure – Data-driven Approaches in PHM – Hybrid Methods – Conclusions New Era in Reliability Sciences and Engineering • Started as an afterthought analysis – In enduing years dismissed as a legitimate field of science and engineering – Worked with small data • Three advances transformed reliability into a legitimate science: – 1. Availability of inexpensive sensors and information systems – 2. Ability to better described physics of damage, degradation, and failure time using empirical and theoretical sciences – 3. Access to big data and PHM techniques for diagnosing faults and incipient failures • Today we can predict abnormalities, offer just-in-time remedies to avert failures, and making systems robust and resilient to failures Seventy Years of Reliability Engineering – Reliability Engineering Initiatives in 1950’s • Weakest link • Exponential life model • Reliability Block Diagrams (RBDs) – Beyond Exp. Dist. & Birth of System Reliability in 1960’s • Birth of Physics of Failure (POF) • Uses of more proper distributions (Weibull, etc.) • Reliability growth • Life testing • Failure Mode and Effect Analysis
    [Show full text]
  • Spanish Clinical Language and Resource Guide
    SPANISH CLINICAL LANGUAGE AND RESOURCE GUIDE The Spanish Clinical Language and Resource Guide has been created to enhance public access to information about mental health services and other human service resources available to Spanish-speaking residents of Hennepin County and the Twin Cities metro area. While every effort is made to ensure the accuracy of the information, we make no guarantees. The inclusion of an organization or service does not imply an endorsement of the organization or service, nor does exclusion imply disapproval. Under no circumstances shall Washburn Center for Children or its employees be liable for any direct, indirect, incidental, special, punitive, or consequential damages which may result in any way from your use of the information included in the Spanish Clinical Language and Resource Guide. Acknowledgements February 2015 In 2012, Washburn Center for Children, Kente Circle, and Centro collaborated on a grant proposal to obtain funding from the Hennepin County Children’s Mental Health Collaborative to help the agencies improve cultural competence in services to various client populations, including Spanish-speaking families. These funds allowed Washburn Center’s existing Spanish-speaking Provider Group to build connections with over 60 bilingual, culturally responsive mental health providers from numerous Twin Cities mental health agencies and private practices. This expanded group, called the Hennepin County Spanish-speaking Provider Consortium, meets six times a year for population-specific trainings, clinical and language peer consultation, and resource sharing. Under the grant, Washburn Center’s Spanish-speaking Provider Group agreed to compile a clinical language guide, meant to capture and expand on our group’s “¿Cómo se dice…?” conversations.
    [Show full text]
  • Hallucinogens and Dissociative Drugs
    Long-Term Effects of Hallucinogens See page 5. from the director: Research Report Series Hallucinogens and dissociative drugs — which have street names like acid, angel dust, and vitamin K — distort the way a user perceives time, motion, colors, sounds, and self. These drugs can disrupt a person’s ability to think and communicate rationally, or even to recognize reality, sometimes resulting in bizarre or dangerous behavior. Hallucinogens such as LSD, psilocybin, peyote, DMT, and ayahuasca cause HALLUCINOGENS AND emotions to swing wildly and real-world sensations to appear unreal, sometimes frightening. Dissociative drugs like PCP, DISSOCIATIVE DRUGS ketamine, dextromethorphan, and Salvia divinorum may make a user feel out of Including LSD, Psilocybin, Peyote, DMT, Ayahuasca, control and disconnected from their body PCP, Ketamine, Dextromethorphan, and Salvia and environment. In addition to their short-term effects What Are on perception and mood, hallucinogenic Hallucinogens and drugs are associated with psychotic- like episodes that can occur long after Dissociative Drugs? a person has taken the drug, and dissociative drugs can cause respiratory allucinogens are a class of drugs that cause hallucinations—profound distortions depression, heart rate abnormalities, and in a person’s perceptions of reality. Hallucinogens can be found in some plants and a withdrawal syndrome. The good news is mushrooms (or their extracts) or can be man-made, and they are commonly divided that use of hallucinogenic and dissociative Hinto two broad categories: classic hallucinogens (such as LSD) and dissociative drugs (such drugs among U.S. high school students, as PCP). When under the influence of either type of drug, people often report rapid, intense in general, has remained relatively low in emotional swings and seeing images, hearing sounds, and feeling sensations that seem real recent years.
    [Show full text]
  • Drugs That Can Cause Delirium (Anticholinergic / Toxic Metabolites)
    Drugs that can Cause Delirium (anticholinergic / toxic metabolites) Deliriants (drugs causing delirium) Prescription drugs . Central acting agents – Sedative hypnotics (e.g., benzodiazepines) – Anticonvulsants (e.g., barbiturates) – Antiparkinsonian agents (e.g., benztropine, trihexyphenidyl) . Analgesics – Narcotics (NB. meperidine*) – Non-steroidal anti-inflammatory drugs* . Antihistamines (first generation, e.g., hydroxyzine) . Gastrointestinal agents – Antispasmodics – H2-blockers* . Antinauseants – Scopolamine – Dimenhydrinate . Antibiotics – Fluoroquinolones* . Psychotropic medications – Tricyclic antidepressants – Lithium* . Cardiac medications – Antiarrhythmics – Digitalis* – Antihypertensives (b-blockers, methyldopa) . Miscellaneous – Skeletal muscle relaxants – Steroids Over the counter medications and complementary/alternative medications . Antihistamines (NB. first generation) – diphenhydramine, chlorpheniramine). Antinauseants – dimenhydrinate, scopolamine . Liquid medications containing alcohol . Mandrake . Henbane . Jimson weed . Atropa belladonna extract * Requires adjustment in renal impairment. From: K Alagiakrishnan, C A Wiens. (2004). An approach to drug induced delirium in the elderly. Postgrad Med J, 80, 388–393. Delirium in the Older Person: A Medical Emergency. Island Health www.viha.ca/mhas/resources/delirium/ Drugs that can cause delirium. Reviewed: 8-2014 Some commonly used medications with moderate to high anticholinergic properties and alternative suggestions Type of medication Alternatives with less deliriogenic
    [Show full text]
  • From Sacred Plants to Psychotherapy
    From Sacred Plants to Psychotherapy: The History and Re-Emergence of Psychedelics in Medicine By Dr. Ben Sessa ‘The rejection of any source of evidence is always treason to that ultimate rationalism which urges forward science and philosophy alike’ - Alfred North Whitehead Introduction: What exactly is it that fascinates people about the psychedelic drugs? And how can we best define them? 1. Most psychiatrists will define psychedelics as those drugs that cause an acute confusional state. They bring about profound alterations in consciousness and may induce perceptual distortions as part of an organic psychosis. 2. Another definition for these substances may come from the cross-cultural dimension. In this context psychedelic drugs may be recognised as ceremonial religious tools, used by some non-Western cultures in order to communicate with the spiritual world. 3. For many lay people the psychedelic drugs are little more than illegal and dangerous drugs of abuse – addictive compounds, not to be distinguished from cocaine and heroin, which are only understood to be destructive - the cause of an individual, if not society’s, destruction. 4. But two final definitions for psychedelic drugs – and those that I would like the reader to have considered by the end of this article – is that the class of drugs defined as psychedelic, can be: a) Useful and safe medical treatments. Tools that as adjuncts to psychotherapy can be used to alleviate the symptoms and course of many mental illnesses, and 1 b) Vital research tools with which to better our understanding of the brain and the nature of consciousness. Classifying psychedelic drugs: 1,2 The drugs that are often described as the ‘classical’ psychedelics include LSD-25 (Lysergic Diethylamide), Mescaline (3,4,5- trimethoxyphenylathylamine), Psilocybin (4-hydroxy-N,N-dimethyltryptamine) and DMT (dimethyltryptamine).
    [Show full text]
  • Eating Disorders: About More Than Food
    Eating Disorders: About More Than Food Has your urge to eat less or more food spiraled out of control? Are you overly concerned about your outward appearance? If so, you may have an eating disorder. National Institute of Mental Health What are eating disorders? Eating disorders are serious medical illnesses marked by severe disturbances to a person’s eating behaviors. Obsessions with food, body weight, and shape may be signs of an eating disorder. These disorders can affect a person’s physical and mental health; in some cases, they can be life-threatening. But eating disorders can be treated. Learning more about them can help you spot the warning signs and seek treatment early. Remember: Eating disorders are not a lifestyle choice. They are biologically-influenced medical illnesses. Who is at risk for eating disorders? Eating disorders can affect people of all ages, racial/ethnic backgrounds, body weights, and genders. Although eating disorders often appear during the teen years or young adulthood, they may also develop during childhood or later in life (40 years and older). Remember: People with eating disorders may appear healthy, yet be extremely ill. The exact cause of eating disorders is not fully understood, but research suggests a combination of genetic, biological, behavioral, psychological, and social factors can raise a person’s risk. What are the common types of eating disorders? Common eating disorders include anorexia nervosa, bulimia nervosa, and binge-eating disorder. If you or someone you know experiences the symptoms listed below, it could be a sign of an eating disorder—call a health provider right away for help.
    [Show full text]